“If we are successful with these current trials, this will be the first time a living medicine of this type has shown a benefit for patients with these types of metabolic diseases,” Miller said.
“If we are successful with these current trials, this will be the first time a living medicine of this type has shown a benefit for patients with these types of metabolic diseases,” Miller said.